Questions Remain Over Ebola Vaccine Trials As Epidemic Subsides

Wall Street Journal: Squabbles Over Testing Methods Hamper Search for Ebola Vaccine
“The Ebola virus outbreak in West Africa created a rare opportunity: New vaccines could be tested, and if they worked, serve as a firewall in future epidemics. It now appears this chance is slipping away amid public health officials’ squabbles over the right way to test vaccines. As a consequence, there may never be a definitive answer about the vaccines’ effectiveness…” (Burton, 4/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.